PCRX
- Pacira BioSciences, Inc.
()
Overview
Company Summary
Pacira BioSciences, Inc. is a pharmaceutical company that specializes in developing and commercializing drug products for acute care settings. The company focuses on providing non-opioid pain management options for patients undergoing surgical and other medical procedures.
Pacira's flagship product is called EXPAREL�. It is a long-acting local analgesic that helps in managing postoperative pain. Unlike traditional pain management drugs that require multiple administrations, EXPAREL is administered as a single dose during surgery, providing pain relief for up to 72 hours. This eliminates the need for additional opioids, minimizing the risk of opioid-related complications such as addiction and respiratory depression.
The company's mission is to innovate and advance the field of postsurgical pain management by reducing the reliance on opioids. Pacira aims to serve patients, healthcare professionals, and the community by providing effective and safer alternatives to traditional pain management methods.
Aside from EXPAREL, Pacira also invests in research and development efforts to explore additional indications and applications for its products. The company's goal is to continuously expand its portfolio of non-opioid pain management options to improve patient outcomes and reduce the overall societal burden associated with opioid use.
In summary, Pacira BioSciences, Inc. is a pharmaceutical company that specializes in the development and commercialization of non-opioid pain management products, with a focus on providing effective alternatives for patients undergoing surgical procedures.